Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 6
Submit an article Journal homepage
58
Views
8
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein

Sari HämäläinenDepartment of Medicine, Kuopio University Hospital, Kuopio, FinlandCorrespondence[email protected]
,
Auni Juutilainen
,
Taru KuittinenDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland
,
Tapio NousiainenDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland
,
Irma MatinlauriDepartment of Clinical Chemistry, Turku University Central Hospital, Turku, Finland
,
Kari PulkkiEastern Finland Laboratory Center and Department of Clinical Chemistry, University of Eastern Finland, Kuopio, Finland
,
Irma KoivulaDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland
&
Esa Jantunen
 show all
Pages 1040-1046 | Received 08 Dec 2009, Accepted 01 Mar 2010, Published online: 17 May 2010

References

  • Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321–328.
  • Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 2004;6:289–293.
  • Zakynthinos E, Kiropoulos T, Gourgoulianis K, Filippatos G. Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases. Heart Lung 2008;37:275–285.
  • Meyer B, Huelsmann M, Wexberg P, et al N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 2007;35:2268–2273.
  • Kotanidou A, Karsaliakos P, Tzanela M, et al Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population. Shock 2009;31:342–347.
  • Brueckmann M, Huhle G, Lang S, et al Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005;112:527–534.
  • Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettilä V. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007;35:1277–1283.
  • Ueda S, Nishio K, Akai Y, et al Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Shock 2006;26:134–139.
  • Rivers EP, McCord J, Otero R, Jacobsen G, Loomba M. Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock. J Intensive Care Med 2007;22:363–373.
  • Nikolaou NI, Goritsas C, Dede M, et al Brain natriuretic peptide increases in septic patients without severe sepsis or shock. Eur J Intern Med 2007;18:535–541.
  • Hämäläinen S, Kuittinen T, Matinlauri I, Nousiainen T, Koivula I, Jantunen E. Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: causes and consequences. Leuk Lymphoma 2008;49:495–501.
  • Persson L, Söderquist B, Engervall P, Vikerfors T, Hansson LO, Tidefelt U. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur J Haematol 2005;74:297–303.
  • Persson L, Engervall P, Magnuson A, et al Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 2004;36:365–371.
  • Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis 1995;21:114–121.
  • Hämäläinen S, Kuittinen T, Matinlauri I, Nousiainen T, Koivula I, Jantunen E. Severe sepsis in autologous stem cell transplant recipients: microbiological aetiology, risk factors and outcome. Scand J Infect Dis 2009;41:14–20.
  • Hughes WT, Armstrong D, Bodey GP, et al 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730–751.
  • Bone RC, Balk RA, Cerra FB, et al Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–1655.
  • Levy MM, Fink MP, Marshall JC, et al 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250–1256.
  • Burjonroppa SC, Tong AT, Xiao LC, Johnson MM, Yusuf SW, Lenihan DJ. Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload. Am J Clin Oncol 2007;30:287–293.
  • Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettilä V. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007;35:1277–1283.
  • Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003;24:341–356.
  • Bettencourt PM. Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives. Heart 2005;91:1489–1494.
  • Witthaut R, Busch C, Fraunberger P, et al Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003;29:1696–1702.
  • Rudiger A, Fischler M, Harpes P, et al In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts. Int J Cardiol 2008;126:28–31.
  • Shor R, Rozenman Y, Bolshinsky A, et al BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 2006;17:536–540.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.